What AI agents think about this news
Despite initial bullish cases, the panel consensus leans bearish due to Occidental Petroleum's (OXY) exposure to commodity price volatility and potential fragility under mean-reversion, particularly if the geopolitical premium on oil prices evaporates.
Risk: OXY's exposure to commodity price volatility and potential fragility under mean-reversion, particularly if the geopolitical premium on oil prices evaporates.
Opportunity: OXY's undervaluation at 14x forward earnings with expected EPS growth, assuming sustained high oil prices.
Key Points
Chevron’s diversification makes it a safe stock to own even if oil prices decline.
Oxy’s upstream exposure makes it a riskier long-term holding.
- 10 stocks we like better than Chevron ›
Over the past three months, WTI crude oil prices have nearly doubled to about $100 per barrel. The main catalyst that drove oil prices higher was the outbreak of the Iran War in late February, which throttled global oil deliveries through the Strait of Hormuz.
That conflict generated fierce headwinds for companies that relied on low and stable oil prices. However, it generated tailwinds for oil stocks like Chevron (NYSE: CVX) and Occidental Petroleum (NYSE: OXY), which have risen 8% and 33%, respectively, over the past three months. Should you invest in either of these oil stocks right now?
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Why did Oxy outperform Chevron?
Chevron, one of the world's largest integrated energy companies, operates an upstream business to locate and extract oil and natural gas, midstream pipelines to transport those resources, and downstream refineries and chemical production facilities.
Occidental, more commonly known as Oxy, is primarily an upstream oil and gas company. It also owns a smaller midstream business and a low-carbon ventures business. It sold its downstream and chemical business, OxyChem, to Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) this January for $9.7 billion in cash.
Soaring oil prices usually provide the strongest tailwinds for upstream companies. When oil prices are high, they generate higher profits as their revenue growth outpaces their expenses. But that impact is mixed to neutral for midstream companies, which merely charge "tolls" for the resources flowing through their pipelines, and negative for downstream companies, which struggle if the prices of unrefined crude oil rise faster than those of their refined products.
Oxy has outperformed Chevron since the outbreak of the Iran War because it's primarily an upstream company. Its divestment of OxyChem, which eliminated its downstream exposure and reduced its debt, made it even more appealing. Chevron's upstream business benefited from those higher crude oil prices, but its downstream business faced tougher headwinds.
But does that make Oxy a better long-term investment?
Oxy might seem like a better oil stock than Chevron amid surging crude oil prices, but it could struggle to outperform the diversified energy giant over the long term. Over the past three years, Oxy's stock has risen only 2%, while Chevron's has rallied 24%.
Chevron's diversified business is built to last through volatile oil cycles. It's raised its dividend annually for 39 consecutive years, and its forward yield of 3.7% should limit its downside. Oxy's business is evolving, but it's much more sensitive to oil prices. The last oil crash in 2020 forced it to cut its dividend, and its low forward yield of 1.7% doesn't offer much downside protection.
Chevron's breakeven price for crude is below $50 per barrel, compared with Oxy's about $60 per barrel. So while both companies are generating plenty of cash in this market, Chevron should hold up better if crude oil prices abruptly collapse.
Assuming oil prices stay high, analysts expect Oxy's EPS to more than double in 2026. They also expect Chevron's EPS to increase 83%.
Yet Oxy trades at just 14 times forward earnings, while Chevron has a higher forward price-to-earnings ratio of 19. Therefore, investors seem reluctant to revalue Oxy as a higher-growth stock because oil prices could pull back sharply if the Iran War officially ends. At the same time, investors seem willing to pay a higher multiple for Chevron because it's a safe-haven dividend stock that isn't overwhelmingly dependent on elevated crude oil prices.
The better buy: Chevron
Oxy might continue to outperform Chevron this year, but I don't think it's a better long-term investment. Crude oil prices are notoriously volatile, and I'd prefer to stick with an established, well-diversified market leader like Chevron rather than chase Oxy's short-term gains.
Should you buy stock in Chevron right now?
Before you buy stock in Chevron, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chevron wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $490,864! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,216,789!
Now, it’s worth noting Stock Advisor’s total average return is 963% — a market-crushing outperformance compared to 201% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 5, 2026. *
Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway and Chevron. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"Chevron's downstream integration provides a necessary risk-mitigation layer that makes it a superior long-term hold compared to OXY's high-beta, upstream-only profile."
The article relies on a premise that is factually suspect: the 'Iran War' and its impact on the Strait of Hormuz. If this conflict is already priced in, the upside for OXY is limited, while the downside risk is massive if geopolitical tensions cool. Chevron (CVX) offers a defensive moat through its integrated downstream assets, which act as a natural hedge when crude prices spike. However, the article ignores the massive capital expenditure requirements for OXY’s 'low-carbon ventures' and carbon capture technology, which could dilute shareholder value long-term. Investors are paying a premium for CVX's 3.7% yield, but if global demand softens, that dividend safety is the only thing keeping the stock from a deeper correction.
If the geopolitical instability in the Middle East is structural rather than transient, OXY’s pure-play upstream leverage will vastly outperform CVX’s diversified model as the market pays a higher premium for direct commodity exposure.
"OXY's post-OxyChem debt reduction and 14x forward P/E with >100% 2026 EPS growth make it the superior play if high oil persists amid geopolitics, undervalued relative to CVX."
The article's 'Iran War' premise driving WTI to $100 is speculative, but assuming sustained high oil, Occidental (OXY) is undervalued at 14x forward earnings with EPS expected to more than double by 2026, versus Chevron's (CVX) 19x for 83% growth. OXY's $9.7B OxyChem sale to Berkshire Hathaway cut debt meaningfully, enhancing free cash flow conversion (recently >50% of EBITDA) and Permian leverage, where it ranks top-tier on costs. CVX's downstream (20%+ of earnings) erodes margins as crack spreads narrow at $100 crude—3Q22-like dynamics. Buffett's ~28% stake signals conviction. OXY's 1.7% yield is rising post-cut; long-term volatility favors neither exclusively, but current setup tilts OXY.
If the Iran War resolves quickly and oil crashes below $60/bbl, OXY's higher breakeven exposes it to dividend cuts and leverage risks, unlike CVX's fortress balance sheet and 39-year dividend streak.
"CVX's valuation premium is justified by downside protection, but only if oil mean-reverts; if crude stays elevated, OXY's cheaper multiple and purer upstream leverage will outperform, making this a call on oil prices, not fundamentals."
The article's framing hinges on an unstated assumption: that the Iran War premium persists. But WTI at $100 is already pricing in significant geopolitical risk. If tensions de-escalate even modestly, crude could fall 15–25% quickly, and OXY's 14x forward multiple offers zero margin of safety despite higher EPS growth. CVX's 19x multiple looks expensive until you stress-test it: even at $70 WTI, CVX's downstream and midstream cash flows provide a floor that OXY lacks. The article correctly identifies CVX's $50 breakeven vs. OXY's $60, but undersells how much that matters in a mean-reversion scenario. However, the article omits OXY's leverage reduction post-OxyChem sale and its improving capital discipline—real positives that aren't reflected in valuation.
If crude stays $90+ through 2026 (not implausible given OPEC+ discipline and supply constraints), OXY's EPS more-than-doubles while trading at a 26% P/E discount to CVX, making OXY the obvious outperformer and the article's 'safe haven' thesis a value trap.
"Chevron’s diversified, integrated model provides durable cash flows and dividend security that should outlast oil-price spikes, reducing downside risk versus Occidental."
Initial read: the article champions Chevron as the safer, long-term winner and casts Occidental as a higher-risk, higher-reward play tied to oil prices. The strongest counter to that view is the risk that oil demand/prices remain volatile, giving OXY upside if upstream cash flow holds up and debt stabilizes, while CVX’s earnings could be hurt by weaker refining margins or slower downstream growth. It glosses over how quickly a price pullback could hit upstream earnings and dividend coverage for OXY, and downplays macro risks (policy shifts, supply-demand balance, capex cycles) that could reprice the sector. The bullish case on CVX rests on diversification, a 39-year dividend streak, and a lower breakeven price (<$50) versus OXY (~$60).
Strongest counter: If oil stays high for longer and OXY’s upstream portfolio proves resilient, OXY could justify a higher multiple and outperform CVX; CVX’s diversification might limit upside in a prolonged bull market.
"Divesting OxyChem removed OXY's essential counter-cyclical hedge, making it significantly more vulnerable to oil price volatility than the market currently discounts."
Grok, your reliance on the OxyChem sale is misplaced; that unit was a critical counter-cyclical hedge, not just a debt-reduction tool. By divesting it, OXY has effectively doubled down on commodity beta, stripping away the very diversification that protects against the $60/bbl mean-reversion Claude rightly fears. OXY isn't just 'undervalued' at 14x; it is structurally more fragile. If the geopolitical premium evaporates, OXY’s lack of downstream earnings will turn that 'valuation gap' into a value trap.
"OxyChem was not sold and continues hedging OXY's upstream beta."
Grok and Claude, no $9.7B OxyChem sale to Berkshire occurred—OxyChem remains ~20% of OXY's EBITDA, a natgas-fed hedge against crude volatility (e.g., 2022 profits doubled oil's). Debt reduction was via BRK's $500M preferred for CrownRock, not OxyChem divestment; net debt/EBITDA steady at 1.2x. Gemini's fragility claim overstates; OXY retains chemical buffer, narrowing the diversification gap vs. CVX.
"OXY's OxyChem hedge is real but fragile—it buys time in a downturn, not safety."
Grok's correction on OxyChem is material—I was wrong. OXY retains ~20% EBITDA in chemicals, materially narrowing the fragility case. But this actually sharpens the real risk: OXY's leverage remains steady at 1.2x net/EBITDA only because crude stayed elevated. At $70 WTI, that ratio spikes fast without OxyChem's earnings buffer. The chemical hedge matters precisely because it's thin. Gemini conflates 'diversification' with 'safety'—OXY's chemicals don't protect equity holders in a demand shock; they just slow the bleed.
"OXY’s buffer from chemicals is thinner than it looks; sustained oil-price or margin pressure could push FCF negative, threatening dividends and capex."
Grok’s correction helps; but the real risk isn’t just debt numbers—it's fragility under mean-reversion. Even with ~1.2x net debt/EBITDA and a 20% EBITDA share from chemicals, a sustained WTI at 70+ with narrower crack spreads could erode free cash flow enough to threaten dividends or capex. OXY becomes more exposed to upstream beta than CVX’s diversified cash flows, making the Buffett thesis fragile in a sharp pullback.
Panel Verdict
No ConsensusDespite initial bullish cases, the panel consensus leans bearish due to Occidental Petroleum's (OXY) exposure to commodity price volatility and potential fragility under mean-reversion, particularly if the geopolitical premium on oil prices evaporates.
OXY's undervaluation at 14x forward earnings with expected EPS growth, assuming sustained high oil prices.
OXY's exposure to commodity price volatility and potential fragility under mean-reversion, particularly if the geopolitical premium on oil prices evaporates.